4 - Table Flashcards
must be assessed for preterm delivery tests determine the total surfactant in the fetal alveoli
Fetal Lung Maturity
normally appears in mature lungs and allows alveoli to remain open throughout the normal cycle of inhal and exhalation
Surfactants
most frequent complication of early delivery Caused by lack of lung surfactants
Respiratory Distress syndrome
reference method
Lecithin/Sphingomyelin Ratio
: maintains alveolar stability
Lecithin
primary component
Lecithin
: serves as the control or basis for lecithin increase
Sphingomyelin
Lecithin/Sphingomyelin Normal ratio:
2:1
Up to 26th week of gestation:
Lecithin < Sphingomyelin
36th week of gestation:
Lecithin = Sphingomyelin
After 36th week of gestation:
Lecithin > Sphingomyelin
L/S Ratio < 1.6:
Respiratory Distress syndrome
Lung surfactant that may be assayed in place of L/S Ratio
Phosphatidylglycerol/
Phosphatidylinositol
Production similar to lecithin except for diabetic mothers (delayed)
Phosphatidylglycerol/
Phosphatidylinositol
Assayed using thin-layer chromatography or Amniostat-FLM
Phosphatidylglycerol/
Phosphatidylinositol
- uses antisera specific for phosphatidylglycerol
Amniostat-FLM
shaking amniotic fluid with 95% ethanol for 15 seconds
Foam/Shake Test
(+) Result: presence of continuous bubbles around the outside edge for 15 minutes
Foam/Shake Test
Semiquantitative measure of the amount of surfactants present
Foam Stability Index
Procedure: amniotic fluid + increasing amount of 95% ethanol
Foam Stability Index
Foam Stability Index Value of (?): indicates fetal lung maturity
≥ 47
Foam Stability Index Value of (?): immature lungs
< 47
Measures the change in (?) which decreases in the presence of phospholipids
Microviscosity
Principle: Fluorescence polarization
Microviscosity
Presence of (?) decreases the microviscosity of amniotic fluid
phospholipids
Microviscosity : Internal Standard
Albumin
Microviscosity Value of (?): indicates fetal lung maturity
≥ 55
are lamellated phospholipids that represent storage form of surfactant
Lamellar bodies
The number of lamellar bodies present in the amniotic fluid correlates with the amount of phospholipid present in the fetal lungs=
RESISTANCE PULSE COUNTING
Lamellar Bodies=FETAL LUNG MATURITY
32,000/MI
+ lamellar bodies increases (?) of amniotic fluid
OD
- Infection of Mother and fetus
TESTS FOR FETAL DISTRESS
- Bilirubin analysis
TESTS FOR FETAL DISTRESS
- Alfafetoprotein(AFP) Test
TESTS FOR FETAL DISTRESS
- Acetylicholinesterase level
TESTS FOR FETAL DISTRESS
- Creatinine concentration
TESTS FOR FETAL AGE
Used for the evaluation of hemolytic disease of the newborn caused by Rh or ABO incompatibilities
Bilirubin Analysis
: bilirubin decreases
Normal pregnancy
: bilirubin increases as a result of fetal red cell destruction
HDN
Principle: optical density of bilirubin (peak @ 450 nm) plotted on a Liley graph
Bilirubin Analysis
Performed for the detection of neural tube defects
Alpha-fetoprotein
Produced by the fetal liver and are present in amniotic fluid and maternal serum
Alpha-fetoprotein
Alpha-fetoprotein : highest AFP concentration
12th to 15th week of gestation
Alpha-fetoprotein : After 15th week of gestation
AFP concentration declines
Alpha-fetoprotein: indicates abnormal result
MoM > 2.0
Used as a confirmatory test for an elevated AFP
Acetylcholinesterase Level
Precaution: sample should not be contaminated with blood
Acetylcholinesterase Level
Increases as the baby nears term and concentration is 1.5 to 2.0 mg/dl prior to 36th week of gestation
Creatinine Concentration
Measured by Jaffe’s reaction
Creatinine Concentration
Creatinine Concentration level that indicates that the pregnancy is over 36 weeks
> 2.0 mg/dl
serum-like fluids formed as ultrafiltrates of plasma which provide lubrication if the cavities where they are found
SEROUS FLUIDS
Primary causes of effusions include:
increased hydrostatic pressure (congestive heart failure)
decreased oncotic pressure (hypoproteinemia)
increased capillary permeability (inflammation and infection)
absorption of fluid into the lymphatic system
Two Membranes of Serous Cavities:
( Parietal Membrane
( Visceral Membrane
: lines the cavity
( Parietal Membrane
: forms a sac around the organs
( Visceral Membrane
If an alteration in the hydrostatic and oncotic pressure in the capillaries of the cavities happens, there will be an increase in fluid volume known as an
EFFUSION
accumulation of serous fluid
EFFUSION
: serous effusions that result from disturbance of the fluid production and regulation between serous membranes
TRANSUDATE
: purulent effusions that form in any body cavity as a result of an inflammatory process
EXUDATE
Force that pushes fluid out of blood capillaries
INCREASED HYDROSTATIC PRESSURE
Force that pushes fluid into blood capillaries
DECREASED ONCOTIC PRESSURE
Chronic/Congenital Heart Failure
INCREASED HYDROSTATIC PRESSURE
Salt and fluid retention
INCREASED HYDROSTATIC PRESSURE
Nephrotic syndrome
DECREASED ONCOTIC PRESSURE
↑ protein – proteinuria
↓ albumin – hypoalbuminemia
DECREASED ONCOTIC PRESSURE
edema – swelling
DECREASED ONCOTIC PRESSURE
Hepatic cirrhosis
DECREASED ONCOTIC PRESSURE
Malnutrition
DECREASED ONCOTIC PRESSURE
Protein-losing enteropathy
DECREASED ONCOTIC PRESSURE
Appearance
TRANSUDATE
EXUDATE
Clear
Cloudy
Fluid:serum protein ratio
TRANSUDATE
EXUDATE
<0.5
>0.5
Fluid:serum LD ratio
TRANSUDATE
EXUDATE
<0.6
>0.6
WBC count
TRANSUDATE
EXUDATE
<1,000/µL
>1,000/µL
RBC count
TRANSUDATE
EXUDATE
Low
>100,000/µL
Spontaneous clotting
TRANSUDATE
EXUDATE
No
Possible
Pleural fluid cholesterol
TRANSUDATE
EXUDATE
<45 to 60 mg/dL
>45 to 60 mg/dL
Pleural fluid: serum cholesterol ratio
TRANSUDATE
EXUDATE
<0.3
>0.3
Pleural fluid: bilirubin ratio
TRANSUDATE
EXUDATE
<0.6
>0.6
Serum-ascites albumin gradient (SAAG)
TRANSUDATE
EXUDATE
> 1.1
<1.1
: pleural fluid collection
Thoracentesis
: pericardial fluid collection
Pericardiocentesis
: peritoneal fluid collection
Paracentesis
SEROUS FLUIDS
Maintained at (?) and transported as soon as possible
room temperature
Only serous fluid for cytology may be (?) – affects viability of specimen
refrigerated (4 to 8OC)
LABORATORY TESTS FOR SEROUS FLUIDS
Physical Examination
Cell count and differential count
Chemistry
Microbiology
Cytology
: appearance, volume, spontaneous clotting
Physical Examination
: protein, cholesterol, LD, fluid-to-blood ratios
Chemistry
: Gram stain, acid fast satin, fungal stain, culture and sensitivity
Microbiology
Present within the synovial cavities found in free-moving joints
SYNOVIAL FLUIDS
A viscous liquid found in the cavities of diarthroses
SYNOVIAL FLUIDS
Formed as an ultrafiltrate of plasma-HYALURONIC ACID
SYNOVIAL FLUIDS
Mucoidal substance
HYALURONIC ACID
SYNOVIAL FLUIDS
Functions:
Reduces friction between bones during movement
Provides nutrients ta articular cartilage
Lessens the shock of joint compression
: needle aspiration of fluid from joints
Arthrocentesis
SYNOVIAL FLUIDS
powdered anticoagulants should never be used
Oxalate, lithium heparin, and powdered EDTA
May produce artifacts that may interfere with crystal analysis
Oxalate, lithium heparin, and powdered EDTA
synovial fluid specimens should be processed (?) to avoid alteration of chemical constituents, cell lysis, micro detection and identification
STAT
Glucose testing: fasting for 6 hours
SYNOVIAL FLUIDS
To establish an equilibrium between plasma and joint glucose levels
Glucose testing
Determines the integrity of the hyaluronic acid-protein complex
MUCIN CLOT TEST
Normal synovial fluid:
tight ropy clot upon the addition of HAc
MUCIN CLOT TEST Reagent:
2 to 5% HAc
MUCIN CLOT TEST Reporting:
Good:
Fair:
Low:
Poor:
solid clot
soft clot
friable clot
no clot
Same proteins with that of plasma except fibrinogen, β2-macroglobulin and α2- macroglobulin
Protein Determination
Normal value: 1 to 3 g/dL
Protein Determination
↑: ankylosing spondylitis, arthritis, arthropathies (Crohn’s disease), gout, psoriasis, Reiter syndrome and ulcerative colitis
Protein Determination
Normal value: 10mg/dL lower than serum
Glucose Determination
↓: infectious joint disorders
Glucose Determination
Diagnosis of gout
Uric Acid Determination
Normal value: 6 to 8 mg/dL
Uric Acid Determination
Results from anaerobic glycolysis in the synovium
Lactic Acid Determination
For rapid differentiation or inflammatory septic arthritis
Lactic Acid Determination
Normal value: <25 mg/dL
Lactic Acid Determination
↑ (as high as 1000 mg/dL): septic arthritis
Lactic Acid Determination
Performed immediately, otherwise refrigerate specimen
Total WBC Count
Clear specimens: no dilution needed
Total WBC Count
Total WBC Count Turbid/Bloody:
NSS + methylene blue
Total WBC Count to promote RBC lysis:
+ hypotonic saline or saline with saponin
Total WBC Count Very viscous specimen:
+ hyaluronidase to 0.5 ml of fluid
+ 0.05% hyaluronidase in PO4 buffer/ml of fluid
incubate for 5 min at 37oC
Total WBC Count Counting chamber:
Neubauer
Normally absent in synovial fluid
CRYSTALS IN SYNOVIAL FLUID
CRYSTALS IN SYNOVIAL FLUID Formation may be due to:
(1) decreased renal excretion (produced elevated blood levels of crystalizing chemical)
(2) degeneration of cartilage and bone
(3) injection of medication
Common crystals formed
Monosodium urate/uric acid
Calcium pyrophosphate
needle-like appearance seen in gout
Monosodium urate/uric acid
Appears yellow in compensated polarized light indicating negative birefringence
Monosodium urate/uric acid
needle-like appearance or in rods seen in Pseudogout
Calcium pyrophosphate
Appears blue in compensated polarized light indicating positive birefringence
Calcium pyrophosphate
Needle-like
Monosodium urate
(-) birefringence
Monosodium urate
Cholesterol
Calcium oxalate
Gout
Monosodium urate
Rhombic squares or rods
Calcium pyrophosphate
(+) birefringence
Calcium pyrophosphate
Pseudogout
Calcium pyrophosphate
Notched, rhombic plates
Cholesterol
Chronic effusion
Cholesterol
Flat, variableshaped plates
Corticosteroid
May exhibit positive and negative birefringence
Corticosteroid
Injections
Corticosteroid
Envelope-like
Calcium oxalate
Renal dialysis
Calcium oxalate
Small particles
Calcium phosphate
No birefringence
Calcium phosphate
Osteoarthritis
Calcium phosphate
stimulates parietal cells to produce HCI
GASTRIN
For intestinal absorption of Vit.B12
INTRINSIC FACTOR
Pepsinogen ->
Pepsin
– catalyzes protein digestion
PEPSIN
GASTRIC Patient Preparation:
12-hour fasting/15-hour fasting
no medication 24 hours prior to collection
should not swallow excessive amount of saliva
should be resting and relaxed
gastric tube inserted in the stomach (buccal/nasal cavity)
- TUBE/INTUBATION METHOD
Oral administration of ion-exchange resin with azure blue dye → free HCl acts on the complex → azure blue is released from the complex and reabsorbed → excreted as part of urine
- TUBELESS METHOD/DIAGNEX BLUE METHOD
requires fasting for 12 or 15 hours
- BASAL GASTRIC SECRETION
total gastric secretion reflects
Basal Acid Output (BAO)
BAO:
0 to 6 mEq/hr
- MAXIMAL GASTRIC SECRETION
requires stimulation
HISTAMINE
PENTAGASTRIN
HISTALOG (BETAZOLE)
Primarily involves qualitative and quantitative measurement of gastric acidity
GASTRIC JUICE CHEMICAL EXAMINATION
: measures free HCl, loosely combined HCl, acid salts and organic acids
Total Acidity
—normal acidity Hyperchlorhydia—duodenal and peptic ulcer
Euchlorhydia
—carcinoma of the stomach, gastric syphilis, chronic gastritis
Hypochlorhydia
—pernicious anemia, advanced gastric cancer, pellagra
Achlorhydia
—complete absence of HCl
Achylia